Dr. Mark Lin, MD

NPI: 1104876713
Total Payments
$1,213
2024 Payments
$14.28
Companies
11
Transactions
17
Medicare Patients
2,630
Medicare Billing
$346,394

Payment Breakdown by Category

Food & Beverage$1,213 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,213 17 100.0%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $381.20 4 $0 (2019)
GE HEALTHCARE $138.16 1 $0 (2017)
AstraZeneca Pharmaceuticals LP $130.51 1 $0 (2018)
Gilead Sciences, Inc. $120.00 1 $0 (2020)
InSightec,Inc $110.46 1 $0 (2023)
ABBVIE INC. $96.54 4 $0 (2024)
Vertos Medical, Inc. $77.74 1 $0 (2019)
PFIZER INC. $62.83 1 $0 (2018)
Novo Nordisk Inc $62.34 1 $0 (2019)
NATUS MEDICAL INCORPORATED $21.01 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $14.28 1 ABBVIE INC. ($14.28)
2023 $192.72 4 InSightec,Inc ($110.46)
2020 $141.01 2 Gilead Sciences, Inc. ($120.00)
2019 $265.08 3 Sunovion Pharmaceuticals Inc. ($125.00)
2018 $351.28 5 Sunovion Pharmaceuticals Inc. ($145.47)
2017 $248.89 2 GE HEALTHCARE ($138.16)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/31/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.28 General
Category: NEUROSCIENCE
05/10/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $15.18 General
Category: NEUROSCIENCE
03/30/2023 InSightec,Inc Exablate (Device) Food and Beverage Cash or cash equivalent $110.46 General
Category: Neurology
02/22/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $33.64 General
Category: NEUROSCIENCE
01/23/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $33.44 General
Category: NEUROSCIENCE
02/27/2020 NATUS MEDICAL INCORPORATED Food and Beverage In-kind items and services $21.01 General
01/21/2020 Gilead Sciences, Inc. Vemlidy (Drug) Food and Beverage In-kind items and services $120.00 General
Category: HBV
09/04/2019 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $125.00 General
Category: CNS
08/20/2019 Vertos Medical, Inc. mild Device Kit (Device) Food and Beverage In-kind items and services $77.74 General
Category: Orthopedic
03/06/2019 Novo Nordisk Inc Food and Beverage In-kind items and services $62.34 General
09/12/2018 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $70.82 General
Category: CNS
06/19/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $130.51 General
Category: Cardiovascular and Metabolism
06/05/2018 Abbott Laboratories AMPLATZER Occluders (Device) Food and Beverage In-kind items and services $12.47 General
Category: Cardiac Arrhythmias and Heart Failure
05/21/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $62.83 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/20/2018 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $74.65 General
Category: CNS
06/26/2017 GE HEALTHCARE DATSCAN (Drug) Food and Beverage Cash or cash equivalent $138.16 General
Category: CONTRAST MEDIA
04/24/2017 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $110.73 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 609 710 $232,764 $81,773
2022 8 708 865 $262,672 $98,729
2021 9 779 973 $286,013 $108,897
2020 11 534 606 $167,391 $56,995
Total Patients
2,630
Total Services
3,154
Medicare Billing
$346,394
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 124 148 $59,809 $22,697 37.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 107 133 $37,753 $13,250 35.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 46 46 $24,258 $8,508 35.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 61 61 $24,670 $7,864 31.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 68 68 $22,304 $7,305 32.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 66 107 $19,177 $7,250 37.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 44 49 $12,524 $4,114 32.8%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 34 34 $11,220 $3,677 32.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $8,748 $2,779 31.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 17 21 $5,472 $2,119 38.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 13 13 $4,479 $1,532 34.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 12 $2,350 $675.99 28.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 174 229 $60,691 $24,819 40.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 94 126 $44,478 $19,420 43.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 101 101 $40,501 $13,494 33.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 74 129 $22,317 $8,053 36.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 58 59 $19,352 $7,042 36.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 72 86 $21,586 $6,937 32.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 33 33 $16,599 $6,344 38.2%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 42 42 $13,860 $4,554 32.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 22 22 $10,692 $3,422 32.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 12 12 $5,772 $1,812 31.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 13 13 $4,394 $1,723 39.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 13 $2,430 $1,107 45.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 157 215 $56,545 $24,528 43.4%

About Dr. Mark Lin, MD

Dr. Mark Lin, MD is a Clinical Neurophysiology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104876713.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lin, MD has received a total of $1,213 in payments from pharmaceutical and medical device companies, with $14.28 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,213).

As a Medicare-enrolled provider, Lin has provided services to 2,630 Medicare beneficiaries, totaling 3,154 services with total Medicare billing of $346,394. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Clinical Neurophysiology
  • Location Washington, DC
  • Active Since 05/12/2006
  • Last Updated 01/20/2010
  • Taxonomy Code 2084N0600X
  • Entity Type Individual
  • NPI Number 1104876713

Products in Payments

  • APTIOM (Drug) $381.20
  • DATSCAN (Drug) $138.16
  • FARXIGA (Drug) $130.51
  • Vemlidy (Drug) $120.00
  • Exablate (Device) $110.46
  • mild Device Kit (Device) $77.74
  • UBRELVY (Drug) $67.08
  • ELIQUIS (Drug) $62.83
  • QULIPTA (Drug) $29.46
  • AMPLATZER Occluders (Device) $12.47

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Clinical Neurophysiology Doctors in Washington